27

SGLT2 inhibitors for longevity — the next metformin?

Empagliflozin and dapagliflozin are showing remarkable results beyond diabetes. Cardioprotective, renoprotective, and some evidence of geroprotective effects. The mechanism (glucose wasting) essentially mimics caloric restriction …